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Abstract
Introduction The role of apoptotic secretory epithelium as a
pro-inflammatory triggering factor of exocrine dysfunction is
currently explored in Sjogren's syndrome patients and in the
nonobese diabetic (NOD) mouse model. Vasoactive intestinal
peptide (VIP) has anti-inflammatory effects in various models of
chronic inflammation. Our goal was to analyse the effect of TNF-
α on apoptotic mediators in isolated acinar cells from NOD
submandibular gland and their modulation by VIP.
Methods Acinar cells were isolated from submandibular glands
of 16-week-old NOD females with salivary flow decline. Age-
matched BALB/c females or eight-week-old NOD females were
used as controls. Apoptotic mediators and TNF-α receptor
expression were assessed by immunoblotting and RT-PCR,
caspase 3 activity was assessed by optical density at 405 nm
with Ac-DEVD-pNA as a substrate and chromatin condensation
by Hoechst stain. They were evaluated in resting conditions and
after a 3.5 or 6 hours of culture with TNF-α. VIP effects in acinar
cells were assessed at 100 nM in TNF-α-treated cultures and
VIP receptor functional assays by radio immunoassay (cAMP) or
enzymatic detection (amylase).
Results NOD acinar cells at 16 weeks present an increased
expression of TNF-α receptor1 together with increased Bax,
tumour protein 53-induced nuclear protein1α (TP53INP1α),
caspase 3 activity and chromatin condensation. Acini from NOD
mice were more sensitive to TNF-α-induced increases of
apoptotic mediators than control cells. VIP inhibited TNF-α-
induced apoptotic events through functional VPAC1 receptors
coupled to the protein kinase A (PKA) signalling pathway.
Conclusions Our results indicate that acinar cells isolated from
submandibular glands of NOD mice with salivary dysfunction
are more sensitive to apoptosis induced by TNF-α which could
be prevented by VIP through a PKA-mediated pathway.
Introduction
Sjögren's syndrome is an autoimmune rheumatic disease
characterised by a progressive loss of exocrine secretion that
affects women in a 9:1 ratio [1-3]. The pathogenic mecha-
nisms of disease are presently unknown and the active involve-
ment of epithelial acinar cells producing inflammatory
mediators has been discussed previously [4]. Hence, studies
on acinar cell cultures from patients with Sjögren's syndrome
and biopsies indicate an aberrant expression and activation of
inflammatory mediators together with defective activity of key
enzymes involved in saliva secretion [4-6].
Observations that acinar cells may be actively involved in the
pathogenesis of Sjögren's syndrome thus encourage the
search for molecules that could mediate these processes,
which could even arise as biomarkers for diagnosis and/or dis-Page 1 of 10
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(NOD) Sjögren's mouse model also supports this view provid-
ing a feasible approach for this search. The NOD mouse
model of Sjögren's syndrome, at the pre-diabetic stage, has
the unique characteristic of developing a deep secretory dys-
function with mild infiltration of the glands [7] consistent with
a structural-dysfunctional aetiology.
The role of apoptosis of secretory epithelium as a triggering
factor of early dysfunction and autoimmune response has
been explored in patients with Sjögren's syndrome and in the
pre-diabetic NOD mouse model. Apoptosis evaluated by ter-
minal UTP nucleotide end-labelling method (TUNEL) and Fas/
FasL-mediated apoptosis have already been reported in both
cases [5,8-10]. In keeping with this, we have shown early sig-
nalling alterations in submandibular glands from NOD mice
involving neural isoform of nitric oxide synthase (NOS 1), cal-
cium-calmodulin kinase II and cGMP [11,12]. Moreover, with
a lower activity of NOS 1 in exocrine glands and higher serum
levels of TNF-α, we recently reported an increased DNA frag-
mentation with increased Bax expression in isolated acinar
cells from NOD submandibular glands at the Sjögren's syn-
drome-like period [13,14]. TNF-α and TNF-α receptors (TNF-
αR) are important cell surface inducers of apoptosis leading to
proteolysis and DNA fragmentation [15]. The ability of TNF-α
to regulate apoptosis in isolated pancreatic acini and experi-
mental pancreatitis has previously been reported [16].
Vasoactive intestinal peptide (VIP) is a neuroimmunopeptide
with several actions on exocrine glands. In addition to inducing
vasodilation and exocrine secretion, VIP was postulated as a
trophic factor for acini [17] and it has shown strong anti-inflam-
matory properties in several models of chronic autoimmune
and immune-mediated inflammatory diseases [18-20].
Regarding NOD mice at the Sjögren's syndrome-like stage,
treatment with VIP in vivo from the fourth week of age reduced
Th1 cytokine levels in the serum and increased IL-10 [21]. In
line with this, VIP was proposed as one of the promising
approaches for the treatment of Sjögren's syndrome based on
VIP gene-transfer experiments in NOD females [3,22].
The aim of the present study was to analyse apoptotic events
involving TNF-α/TNF-αR in isolated acini from NOD mice sub-
mandibular glands and to explore the ability of VIP to modulate
these effects. In addition to Bax and other pro-apoptotic and
anti-apoptotic signals, we investigated the expression of two
proteins encoded by tumour protein 53-induced nuclear pro-
tein 1 gene (TP53INP1), TP53INP1α and β whose over-
expression was associated to Bax expression and apoptosis
[23,24]. Our present data indicate that isolated acini from sub-
mandibular glands of NOD mice present increased chromatin
condensation, TNF-αR, Bax and TP53INP1α expression, and
caspase 3 activity than normal BALB/c mice. TNF-α was more
potent in inducing pro-apoptotic mediators and nuclear chro-
matin condensation in NOD acinar cells. VIP inhibited TNF-α-
induced apoptotic events through a cAMP-mediated pathway.
Materials and methods
Animals
NOD and BALB/c female mice were bred and maintained in
the Central Animal Care Facility at the School of Exact and
Natural Sciences, University of Buenos Aires. Mice were
fasted overnight with water ad libitum before used. They were
routinely tested for blood glucose levels (Wiener Laboratory,
Rosario, Argentina) and considered pre-diabetic as their val-
ues of serum glucose on two occasions over a 24-hour period
did not significantly differ from those of control mice (0.9 ± 0.1
g/l, n = 27). NOD mice of 16 weeks of age used throughout
this study presented a reduced saliva flow rate (about 40%
reduction) as compared with BALB/c control mice. All studies
were conducted according to standard protocols of the Ani-
mal Care and Use Committee of the School of Exact and Nat-
ural Sciences, University of Buenos Aires, Argentina.
Submandibular acinar cell isolation and treatments
Submandibular glands were quickly removed and immediately
transferred to ice-cold RPMI 1640 10% fetal bovine serum
(FBS) (Gibco, Invitrogen, Carlsbad, CA, USA). Acinar cell iso-
lation was performed as previously described [25]. For each
experiment, the tissue coming from about 10 NOD and 10
BALB/c submandibular glands (pooled for each mice group)
was minced into small fragments and digested in 2.5 ml RPMI
containing Collagenase IV (Sigma, St Louis, MO, USA) (100
U/ml), 10% FBS and 0.1 g/L soybean trypsin inhibitor at 37°C
in a shaking water bath for 10 minutes (120 cycles/minute),
dispersed with a plastic pipette, filtered through a nylon mesh
(150 meshes).
The acinar cells were centrifuged at 400 g for 10 seconds for
three times in fresh RPMI medium containing 10% FBS and
were seeded on flat-bottom 24-well microtitre plates (Corning
Glass, Corning, NY, USA) and incubated for two hours at
37°C in a humidified incubator with 5% carbon dioxide to sep-
arate glandular immune adherent cells. The purified suspen-
sion presented a homogenous population of acinar cells with
a minimal presence (less than 5%) of mononuclear immune
cells as revealed by flow cytometry analysis. Viability of acinar
cell suspension was stated by acridine orange/propidium
iodide staining and trypan blue exclusion [26]. Resulting acini
were plated and cultured in RPMI 1640 10% FBS for the
times indicated for each determination. When used, recom-
binant TNF-α (Promega, Madison, WI, USA) (5 and 10 ng/ml)
was added to acinar cells for 3.5 hours for RT-PCR experi-
ments or six hours for nuclear condensation, caspase 3 activity
and immunoblotting experiments. In some experiments, cells
were pre-incubated for 30 minutes with 100 nM VIP (Neosys-
tem, Strasbourg, France) before TNF-α addition in the pres-
ence or absence of H89 (1 μM).Page 2 of 10
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Cells were fixed with 4% paraformaldehyde in PBS (v/v) for 20
minutes at 4°C, exposed to 0.05 g/l Hoechst 33258 dye in
PBS for 30 minutes at room temperature, washed three times
with PBS and, finally, mounted in 50% glycerol in PBS (v/v),
as previously described [27]. Fluorescent nuclei with apop-
totic characteristics were detected by microscopy under ultra-
violet illumination at 365 nm. The images (400×) were
photographed with a Nikon Coolpix 5000 (Nikon, Tokyo,
Japan) and digitalised. For differential cell counting at least
500 cells were analysed.
Immunoblotting
Acinar cells were homogenised at 4°C in 50 mM Tris-HCl
buffer at pH 7.5 with 0.15% Triton X-100 (SIGMA, St Louis,
MO, USA) and protease inhibitors as previously reported [12].
Once centrifuged at 5000 g for 10 minutes at 4°C, superna-
tants were frozen at -80°C until used and an aliquot of each
sample was separated for protein determination. Extracts (50
μg protein/lane) were subjected to 10% SDS-PAGE, trans-
ferred onto nitrocellulose membranes and immunoblotted with
rabbit polyclonal anti-Bax (N-20, Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA), rat monoclonal anti-TP53INP1 (E-
12) or goat polyclonal anti-actin (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA) used as primary antibodies. Mem-
branes were incubated overnight and revealed with peroxi-
dase-conjugated secondary antibodies (1:3000) followed by
enhanced chemiluminescence detection system (ECL; Pierce,
Rockford, IL, USA). Densitometric analysis of protein levels
was performed with ImageQuant software (GE Healthcare,
Chalfont St Giles, UK).
RNA extraction and PCR amplification of cDNA
Total RNA was extracted from acinar cells with Trizol (Gibco,
Carlsbad, CA, USA) as described [14]. Reverse-transcribed
cDNAs were amplified using specific primers for Bax,
TP53INP1s, TNFR1 and BclxL with glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) primers serving as an internal
control. GAPDH is considered an appropriate housekeeping
gene in this model [8]. 5'-Bax: 5'-GGAATTCCAAGAAGCT-
GAGCGAGTGT-3' and 3'-Bax: 5'-GGAATTCTTCTTCCA
GATGGTGAGCGAG-3' were used as forward and reverse
primers, respectively. The reaction yielded a cDNA fragment
394 base pairs (bp) in length [28]. For TP53INP1: forward 5'-
GCACCCTTCAGTCTTTTCCTGTT-3' (position 718) and
TP53INP1 reverse 5'-GGAGAAAGCAGGAATCACTTG-
TATC-3' (position 886) [23]. After denaturing for three min-
utes at 96°C, 30 cycles of amplification using a step program
(96°C, 40 seconds; 58°C (for bax), 55°C (for TP53INP1), 30
seconds and 72°C, 1 minute) and a final extension at 72°C 10
minutes was performed.
VPAC1 forward 5'-GTGAAGACCGGCTACACCAT-3'
reverse 5'-TGAAGAGGGCCATATCCTTG-3' and VPAC2
forward 5'-CCAAGTCCACACTGCTGCTA-3' reverse 5'-
CTCGCCATCTTCTTTTCAG-3'. PCR conditions for VPAC1/
VPAC2 were 94°C for 10 minutes, 35 cycles of 94°C for 45
seconds, 55°C for 45 seconds, 72°C for 90 seconds and
72°C for 10 minutes while for Bax were 96°C for 3 minutes,
30 cycles of 58°C for 30 seconds, 72°C for 1 minute and
72°C for 10 minutes. PCR, products were size fractionated on
2% agarose gels and visualised by staining with ethidium bro-
mide using a size molecular marker. Scion Image for Windows
program (Scion Corporation, Frederick, MA, USA) for
processing. The analysis of images was used to measure
areas and the ratio of interest gene vs. housekeeping gene is
depicted in each graph.
Caspase 3 activity
After appropriate treatments, cells were harvested by centrifu-
gation at 1000 g for five minute at 4°C. Cell pellets were
washed with 1 ml of PBS, then suspended in 150 μl of lysis
buffer (50 mM Tris-HCL, pH 7.4; 1 mM EDTA; 10 mM EGTA;
10 μM digitonina) containing 1 mM phenylmethylsulphonyl flu-
oride protease inhibitor and maintained for 30 minutes on ice.
Cell debris was removed by centrifugation at 15,000 g for 20
minutes at 4°C, 144 μl of cell lysates were transferred to a
microplate, 6 μl of 7.8 mM Ac-DEVD-pNA were added and the
volume completed to 300 μl with the reaction buffer (100 mM
HEPES, pH 7.5, 0.5 mM EDTA, 5 mM DTT, 20% glycerol).
Plates were covered and incubated at 37°C for two to six
hours until a yellowish colour was observed. The amount of
released p-nitroaniline was measured spectrophotometrically
at 405 nm in a microplate reader (BioRad, Hercules, CA,
USA).
cAMP levels, amylase activity and secretory profile
Acinar cells were assayed for their functional ability to secrete
salivary protein and stimulate cAMP levels in response to VIP
by determining basal and VIP-stimulated cAMP by RIA and
amylase secretion as previously reported [12,25,29]. Acinar
suspension was incubated for 15 minutes in the absence and
presence of 100 nM VIP and amylase activity was determined
at 30 minutes in the intracellular fraction and in the superna-
tants (secreted). Percentage of secretion was calculated as
the ratio of secretion over total amylase (total amylase is that
present in intracellular plus supernatant fractions) and normal-
ised per mg protein. Protein detection was performed using
the Micro BCA Protein Assay (Pierce, Rockford, IL, USA) in
acinar suspension aliquots.
Statistical analysis
Statistical significance of differences was determined by the
two-tailed t test for independent populations. When multiple
comparisons were necessary, the Student-Newman-Keuls
test was used after analysis of variance. Differences between
groups were considered significant at P < 0.05.Page 3 of 10
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Apoptosis pattern of acinar cells in resting conditions
Figure 1 shows acinar cell suspension isolated from sub-
mandibular glands of NOD and control BALB/c mice, both at
16 weeks of age, stained with acridine orange and propidium
iodide. Viable cells fluoresce green under dark field fluores-
cence microscopy, while nonviable cells fluoresce orange. We
investigated further whether freshly isolated acinar cells from
NOD mice presented signals of apoptotic events in resting
unstimulated conditions (Figure 2). Control acini were
obtained from age-matched BALB/c mice and from NOD mice
at eight weeks. As shown in Figures 2a and 2b, an increased
count of apoptotic acinar cells by Hoechst staining along with
an increased expression of Bax at mRNA and protein levels in
NOD mice acini compared with control mice was found. An
over-expression of TP53INP1 has been associated with Bax
expression and apoptosis in acinar cells but not in ductal or
Langerhans cells in the pancreas of a mouse model of pancre-
atitis [24], so we determined TP53INP1 α and β expression in
NOD acinar cells. Figure 2c shows TP53INP1 α and β mRNA
and protein expression increased only in NOD mice acini com-
pared with BALB/c acinar cells. A faint increase of the
TP53INP1α isoform was detected at eight weeks in NOD
mice only at the protein level.
TNF-α-induced apoptosis in NOD acinar cells
With the knowledge that TNF-α/TNF-αR interaction mediates
apoptosis in pancreatic acinar cells [16] and the observation
that acinar cells isolated from NOD submandibular glands pre-
sented several signals of apoptotic events in resting condi-
tions shown above, we first analysed TNF-αR expression in
NOD and control isolated acinar cells in basal conditions. Fig-
ure 3 shows an increased expression of TNF-αR1 in NOD
acini in resting conditions with a negligible expression of TNF-
αR2 in both cases (not shown).
With the aim of investigating the ability of TNF-α to induce
apoptosis in acinar cells from NOD and control mice sub-
mandibular glands, we then determined the effect of TNF-α at
5 and 10 ng/ml. Figures 4a and 4b show that TNF-α induced
TP53INP1α expression at 5 ng/ml only in NOD acini and this
effect was paralleled by an increased condensation of nuclear
chromatin. At a higher concentration (10 ng/ml), the cytokine
could reproduce these effects on normal acinar cells (Figure
4).
At the concentration that TNF-α induced chromatin condensa-
tion and TP53INP1 expression only in NOD acini, it also
increased caspase 3 activity, and increased expression of Bax,
TP53INP1 and its own receptor TNF-αR1, but it did not modify
the expression of BclxL (Figure 5). To analyse whether VIP
could prevent or modulate this effect of TNF-α, we performed
the same experiments in the presence or absence of the neu-
ropeptide.
Inhibitory effect of VIP on TNF-α-induced apoptosis
We first studied the effect of VIP on apoptotic mediators
induced by TNF-α. The preincubation of acinar cells with 100
nM VIP prevented the inducing effect of TNF-α on all of the
apoptotic events shown (Figure 5). As it is shown in Figures
5a (caspase activity) and 5b (TP53INP1 and bax) TNF-α was
unable to induce these factors in control acinar cells although
it did increase their expression/activity in the NOD suspen-
sion. Moreover, VIP only reduced their expression in NOD
acini suggesting that VIP modulation mainly affects TNF-α
upregulated factors. To identify and functionally characterise
VIP receptors involved in this acinar cell preparation, we inves-
tigated VIP receptor expression, cAMP accumulation and amy-
lase secretion. Figure 6a shows that acinar cells express
VPAC1 receptors in both strains of mice. In contrast VPAC 2
expression could not be detected at any condition tested (not
shown).
Figure 6b shows that VIP receptors on acinar cells are func-
tional because 100 nM VIP stimulated cAMP accumulation
and amylase secretion at the same concentrations used for
inhibiting apoptotic signals. Note that in basal and VIP-stimu-
lated conditions acinar cells present a lower amylase secretion
confirming in this acinar cell preparation the results shown pre-
viously in studies of in vivo salivary flow stimulation (Figure 6b)
[29]. Finally, as expected for a VPAC1-cAMP-PKA-mediated
effect, VIP failed to reverse apoptotic signals induced by TNF-
α in acinar cells in the presence of PKA inhibitor H89 (Figure
6c). VIP alone did not modify the basal expression of apoptotic
mediators or the condensation of chromatin in NOD and con-
trol acini (not shown).
Discussion
We presented evidence to indicate that acinar cells isolated
from submandibular glands of NOD mice with salivary dys-
function are more sensitive to TNF-α-induced apoptotic
Figure 1
Acinar cell suspension. Acinar cells were stained with acridine orange 
and propidium iodide (AO/PI). Nuclei of live cells fluoresce green with 
AO/PI under fluorescence microscopy. Arrows indicate apoptotic cells 
with yellow-orange fluorescence. These images are representative of 
five others from similar experiments run with independent non obese 
diabetic (NOD) and BALB/c acinar samples. Magnification ×200.Page 4 of 10
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effects. We also showed that NOD acinar cells are functional
for cAMP signalling and amylase secretion through VIP recep-
tors, although they express a number of apoptotic signals and
mediators activated in resting conditions that were enhanced
with TNF-α and prevented by VIP.
Our conclusions are based on three main observations. First,
acinar cells isolated from submandibular glands of NOD mice
undergoing salivary flow decline showed increased condensa-
tion of nuclear chromatin, caspase 3 activity and Bax, TNF-
αR1 and TP53INP1α expression compared with control mice.
Second, TNF-α enhanced apoptotic events in NOD acini at a
concentration that did not modify various apoptotic mediators
in BALB/c acini. However, the treatment of normal BALB/c
acinar cells with a higher (10 ng/ml) TNF-α concentration
reproduced the apoptotic pattern of resting NOD acini. Third,
pretreatment of NOD acini with VIP acting on functional
VPAC1 receptors prevented apoptotic events induced by
TNF-α.
Apoptosis mediated through Fas/FasL has already been
reported in salivary glands of NOD and NOD-scid mice with
increased Fas expression in both acinar and ductal cells at 18
weeks of age [8]. In contrast, FasL was detected as earlier as
eight weeks in NOD submandibular glands [8]. Similarly, cas-
pase 3 gene expression appeared to be increased in sub-
mandibular glands of the Sjögren's syndrome-susceptible
strain C57BL6/NOD.Aec1Aec2 mice at eight weeks of age
but returned to baseline values at the 12th week of age [30].
This supports the notion that early defects in glandular home-
ostasis leading to apoptotic events might predispose them to
the autoimmune response.
Figure 2
Apoptosis of acinar cells from NOD submandibular glands. (a) Chromatin condensation and mRNA and protein expression of (b) Bax and (c) 
TP53INP1 were determined in acinar cells from non obese diabetic (NOD) at 16 and 8 weeks of age and 16 week old BALB/c mice. (c) The light 
grey bar corresponds to TP53INP1β while TP53INP1α is in dark bars. The count of condensed nuclei at 400× after Hoechst staining and RT-PCR 
or immunoblotting for apoptotic mediator expression were performed as indicated in Material and methods. These images are representative of sim-
ilar experiments run with independent NOD and BALB/c acinar samples. Results shown on the right side of representative photographs represent 
the percentage of apoptotic cells as mean ± standard error of the mean (SEM) of at least six experiments. (a) *P < 0.05 vs. BALB/c 16 weeks. The 
intensity of mRNA or protein bands relative to GAPDH or actin, respectively, were depicted as the mean ± SEM of at least three experiments. (b) *P 
< 0.05 vs. NOD 8 weeks TP53INP1α; **P < 0.01 vs. BALB/c 16 weeks TP53INP1α and Bax.
Figure 3
Increased expression of TNF-αR1 in NOD acini. TNF-αR1 mRNA 
expression in isolated acini from non obese diabetic (NOD) and control 
mice was determined by RT-PCR as described in Materials and meth-
ods. Bands shown are representative of four experiments and results 
shown for TNF-αR1 band intensity are means ± standard error of the 
mean of ratios relative to GAPDH for independent NOD (n = 8) and 
BALB/c (n = 6) samples in experiments run similarly. *P < 0.05 vs 
BALB/c cells.Page 5 of 10
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characteristic apoptotic pattern with increased Bax expres-
sion, chromatin condensation and caspase 3 activation adding
new evidence to previously reported apoptosis markers in
NOD whole gland samples [8-10] and DNA fragmentation in
NOD acinar suspension [14]. The signs of apoptosis were
detected in acinar cells from NOD mice at 16 weeks of age
when they had already developed a saliva flow reduction
higher than 40% compared with BALB/c mice. Of note, at
eight weeks of age NOD females showed normal salivary func-
tion [12] and there was no detectable apoptosis of acinar
cells, suggesting that apoptotic processes, if present, might
be incipient at this early stage and not detectable by the meth-
ods used.
Among the pro-apoptotic mediators determined in NOD aci-
nar cells, here we chose to analyse α and β TP53INP1 isoform
expression. The overexpression of nuclear TP53INP1s stimu-
lates the transactivation activity on the Bax promoter and
induces apoptosis in cell lines and the exocrine pancreas in a
model of pancreatitis [23]. Interestingly, immunohistochemical
analyses revealed that increased expression of TP53INP1 dur-
ing the acute phase of pancreatitis was only observed in acinar
cells with no staining of Langerhans islets or pancreatic duct
cells [24]. Here we showed that NOD acini had an enhanced
expression of TP53INP1α in resting conditions from the eighth
week of life and when stimulated with TNF-α. The β isoform did
not show significant changes as it was also described in mice
pancreatitis [23]. The modulation of nuclear proteins Ku70
and Ku80 in a caspase 3-dependent pathway was proved in
oxidative stress-induced apoptosis of AR42J pancreatic aci-
nar cells [31]. A sparing action of these partner Ku70 and
Ku80 nuclear proteins was suggested, as one subunit may
stabilise the other subunit under certain conditions [31].
To our knowledge, this is the first report on an increased
TP53INP1 expression in acinar cells from salivary glands in
relation to apoptosis, either in the NOD model or in normal
mice glands treated with TNF-α. Regarding the NOD model, it
is also remarkable that the higher TP53INP1 protein expres-
sion observed co-occurred with a lower amylase secretion in
functional assays of the acinar cell suspensions from low
secretory capacity animals. However, the involvement of
TP53INP1α expression previous to overt apoptosis and sali-
vary dysfunction in NOD mice and its putative value as a
biomarker for patients with Sjögren's syndrome needs further
research.
Our results indicate that an increased expression of TNF-αR
and a higher sensitivity to TNF-α underlies the inflammatory/
Figure 4
TNF-α-induced chromatin condensation and TP53INP1α expressionI  r i . The effect of TNF-α (5 and 10 ng/ml) on both BALB/c and non obese diabetic 
(NOD) isolated acinar cells was determined by (a) TP53INP1α expression and (b) Hoechst staining as in Figure 1 after six hours incubation of iso-
lated acini with the cytokine at 37°C with 5% carbon dioxide. Gel bands and apoptotic acini shown are representative of separate experiments with 
NOD and control cells. Results on percentage of apoptotic cells and TP53INP1 expression are means ± standard error of the mean of five and three 
experiments respectively. *P < 0.05 vs. basal values of NOD acini; **P < 0.01 vs 5 ng/ml TNF in BALB/c cells.Page 6 of 10
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mandibular glands of NOD mice in the Sjögren's syndrome-
like stage. Increased levels of plasma and saliva TNF-α in NOD
mice at the Sjögren's like stage have been reported [13,32].
Interestingly, increased levels of TNF-α in saliva and serum of
pre-diabetic NOD mice were shown to correlate with the
decline of salivary flow but not with the severity of mononu-
clear infiltrates measured as focus score and ratio of inflamed
area to total glandular area [12,32]. Similarly, compared with
age-matched BALB/c mice, we have shown increased bioac-
tive TNF-α produced by peritoneal macrophages of NOD
females concomitant with a decline of salivary flow but no
signs of severe mononuclear infiltration [33].
Enhanced expression of six of 30 TNF-α superfamily genes
was detected at earlier ages in RNA from freshly extracted
submandibular glands of C57BL/6.NOD-Aec1Aec2 strain
used as a model of Sjögren's syndrome [30]. These results are
consistent with previously reported identification of Tnfsf6
(FasL) y Ox40 protein from the TNF superfamily as a potential
candidate SjS susceptibility marker [34]. Likewise, evidence
that autoantigens fodrin, SS-A (Ro) and SS-B (La), in human
salivary gland cells treated with TNF undergo a striking redis-
tribution during apoptosis and relocate to the cell membrane
of apoptotic cells has been presented [35]. On the other hand,
pancreatic acini produce TNF-α and express TNF-αR1 in a
model of pancreatitis suggesting a role of TNF-α in the auto-
crine regulation of apoptosis [16]. In line with this, NOD acini
from submandibular glands showed an increased expression
of TNF-αR1 in resting conditions that was enhanced by TNF-
α, while several pro-apoptotic mediators but not the anti-apop-
totic BclxL were also up-regulated by the cytokine. NOD acini
required a lower concentration of TNF-α to promote chromatin
condensation, pro-apoptotic mediators and caspase 3 activa-
tion than BALB/c acini consistent with a higher expression of
its own receptor in the former.
Proteomic and genomic approaches in NOD mice and
patients samples have allowed the identification of several
apoptotic and inflammatory factors as well as acinar cell com-
ponents as putative biomarkers of Sjögren's syndrome [36-
38]. Interestingly, a lower amylase expression in saliva has
been proposed as a biomarker in a proteomic approach in
patients [36]. However, a correlation between biomarkers, sal-
ivary dysfunction and common immunopathological signatures
Figure 5
VIP inhibition of TNF-α-induced apoptotic events. (a) Caspase 3 activity, TNF-αR1, (b) TP53INP1s, Bax and BclxL mRNA expression were deter-
mined after TNF-α (5 ng/ml) incubation as in Figure 2 in the presence or absence of 100 nM vasoactive intestinal peptide (VIP) as described in 
Materials and methods. Results of caspase activity are means ± standard error of the mean (SEM) of at least four experiments run independently. 
The intensity of the bands for TNF-αR1, TP53INP1s, Bax and BclxL relative to GAPDH are shown as means ± SEM ratios from at least three exper-
iments run independently with non obese diabetic (NOD) (n = 12) and BALB/c (n = 10) samples. *P < 0.05; **P < 0.01.Page 7 of 10
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not found [37,38].
Finally, VIP inhibited TNF-α-induced apoptotic events in NOD
acinar cells. VIP has been proved as a potent anti-inflammatory
molecule in several models of autoimmune inflammatory dis-
ease [18-20]. When given every other day to pre-diabetic
NOD females between the 4th and 16th week, it reduced
serum Th1 cytokine IL-12 and increased IL-10 [21]. In addi-
tion, VIP transfer experiments onto NOD pre-diabetic females
reduced the autoimmune response against submandibular
glands and reversed salivary flow decline [22]. In line with this,
in vitro treatment of NOD macrophages with VIP reduced
TNF-α, nitric oxide and IL-12 and increased IL-10 produced by
peritoneal macrophages [31]. Although VIP has also been
shown to inhibit apoptosis through the inhibition of the expres-
sion of Fas ligand in activated T lymphocytes [39,40] data are
lacking about VIP on TNF-α-mediated apoptosis in immune
and non-immune cells. Here we showed that the anti-apop-
totic effect of VIP on acinar cells induced with TNF-α involved
direct activation of functional amylase secretion-coupled VIP
receptors through a PKA-dependent pathway.
Conclusions
An increased expression of TNF-αR and a higher sensitivity to
TNF-α underlies the inflammatory/apoptotic profile displayed
by acinar cells isolated from submandibular glands of NOD
mice in the Sjögren's syndrome-like stage. The anti-inflamma-
tory neuropeptide VIP was able to inhibit TNF-α-induced
apoptotic events through a PKA-mediated pathway. Acinar
cells isolated from salivary flow declining glands might serve
as a suitable model to analyze combined information about
identified biomarkers, cell secretion functional studies and dis-
ease severity.
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